MLM:NYSEMartin Marietta Materials, Inc. Analysis
Data as of 2026-03-10 - not real-time
$612.52
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Martin Marietta Materials posted a disappointing earnings beat and missed revenue expectations for Q4 2025, with sales falling year‑over‑year. The RSI is in oversold territory, suggesting a short‑term technical bounce, while the MACD remains bearish, indicating lingering downside pressure. The stock is trading just above a clear support level and volatility has spiked to a high 30‑day range, though the beta remains modest, tempering market‑wide swings. A comparison of the current market price to the discounted cash‑flow estimate flags the equity as overvalued, and the forward‑looking earnings multiple remains elevated relative to peers.
Fundamentally, the company sustains a modest dividend with a low payout ratio, but carries a substantial debt load that compresses cash flow flexibility. Growth in aggregates and specialty chemicals offers a balanced exposure to both cyclical construction demand and higher‑margin specialty markets, supporting a blend investment profile. The combination of a solid dividend, resilient market position, and long‑term infrastructure demand underpins a cautiously optimistic outlook despite the near‑term valuation stretch.
Fundamentally, the company sustains a modest dividend with a low payout ratio, but carries a substantial debt load that compresses cash flow flexibility. Growth in aggregates and specialty chemicals offers a balanced exposure to both cyclical construction demand and higher‑margin specialty markets, supporting a blend investment profile. The combination of a solid dividend, resilient market position, and long‑term infrastructure demand underpins a cautiously optimistic outlook despite the near‑term valuation stretch.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Oversold RSI indicating potential bounce
- Bearish MACD signaling continued pressure
- Proximity to technical support level
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation gap between market price and DCF
- High debt burden limiting financial flexibility
- Stable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term infrastructure demand supporting aggregates business
- Diversified specialty chemicals segment adding margin upside
- Sustainable dividend offering income component
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin18.49%
P/E Ratio37.5
ROE10.16%
ROA4.99%
Debt/Equity59.87
P/B Ratio3.7
Op. Cash Flow$1.8B
Free Cash Flow$-715750016
Technical Analysis
TrendBullish
RSI34.4
Support$589.64
Resistance$710.97
MA 20$667.05
MA 50$656.23
MA 200$612.02
MACDBearish
VolumeStable
Fear & Greed Index77.38
Valuation
Fair Value$314.90
Target Price$702.46
Upside/Downside14.68%
GradeOvervalued
TypeBlend
Dividend Yield0.54%
Risk Assessment
Beta0.68
Volatility33.88%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.